|
Volumn 31, Issue 4, 2010, Pages 598-602
|
Do burn patients cost more? the intensive care unit costs of burn patients compared with controls matched for length of stay and acuity
a b,c b,c b,c b,c b,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
ANALGESIC AGENT;
ANTIINFECTIVE AGENT;
ANXIOLYTIC AGENT;
CASPOFUNGIN;
FLUCONAZOLE;
MEROPENEM;
SEDATIVE AGENT;
VORICONAZOLE;
ADULT;
ARTERIAL GAS;
ARTICLE;
BURN;
BURN PATIENT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
COST OF ILLNESS;
DISEASE SEVERITY;
FEMALE;
HEALTH CARE COST;
HEALTH CARE PERSONNEL;
HOSPITAL CHARGE;
HUMAN;
INTENSIVE CARE UNIT;
LABORATORY TEST;
LENGTH OF STAY;
MALE;
PHYSIOTHERAPY;
WOUND DRESSING;
ADULT;
ANTI-INFECTIVE AGENTS;
AUSTRALIA;
BANDAGES;
BURNS;
CASE-CONTROL STUDIES;
FEMALE;
HOSPITAL COSTS;
HOSPITAL MORTALITY;
HUMANS;
HYPNOTICS AND SEDATIVES;
INTENSIVE CARE UNITS;
LENGTH OF STAY;
MALE;
PHYSICAL THERAPY MODALITIES;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
|
EID: 77954957660
PISSN: 1559047X
EISSN: 15590488
Source Type: Journal
DOI: 10.1097/BCR.0b013e3181e4d6a4 Document Type: Article |
Times cited : (27)
|
References (10)
|